• Dry Cracked Skin
  • Impetigo
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

The Weekly Roundup: November 28 - December 2


ICYMI, this week we had stories about characteristics of generalized pustular psoriasis, the psychosocial impact of vitiligo, new laser treatments for acne, and more.

Are You Prepared for Potential Tax Law Changes?

In this month's Finance & Practice Management article, Carole C. Foos, CPA, and David B. Mandell, JD, MBA, give an overview of potential upcoming tax law changes.

Baseline Characteristics of Patients With Generalized Pustular Psoriasis

Aaron S. Farberg, MD, and Jeffrey Crowley, MD, review the demographics of people with generalized pustular psoriasis including age, race, and comorbidities.

Study Results for Patients With Generalized Pustular Psoriasis

Aaron S. Farberg, MD, and Jeffrey Crowley, MD, examine the results of a study of generalized pustular psoriasis, discussing flares and common signs and symptoms.

FDA Clears Accure Laser System for Acne Treatment

Accure’s system is the first 1726nm-based laser device with both FDA and CE Mark clearances.

The Psychosocial Impact of Vitiligo

Vitiligo, an autoimmune skin condition that causes depigmentation, can have a large effect on a patient’s quality of life and psychosocial well-being.

Future of Plaque Psoriasis Management

Drs Mark G. Lebwohl and Alice B. Gottlieb discuss future expectations in the treatment of plaque psoriasis.

Surgical Treatment of Vitiligo

A recent systematic review on surgical therapies for vitiligo examined surgical therapies such as punch grafting, suction blister epidermal grafting, and cellular grafting techniques.

Continuing Medical Education: Three Things to Know About Pustular Psoriasis

Pustular psoriasis (PP) is a rare and potentially serious inflammatory skin disorder affecting about 1% of patients with psoriasis.

Initiating Patient Conversations Around Vitiligo Management

Experts in dermatology share their approaches to communicating with patients about their vitiligo, highlighting family history and genetic awareness.

Treatment and Patient Guidance in Vitiligo

Nada Elbuluk, MD, and David Rosmarin, MD, discuss the role of the health care provider in helping patients understand their vitiligo and treatment options.

Update on New Laser Treatments for Acne

Newly approved laser treatments can be an effective option for the treatment of this common skin disorder.

Pointers with Portela: Skin Care Quiz

In this week’s Pointers with Dr Portela, the 208SkinDoc, asks consumers about the basics of skin health and skin care.

POLL: How Many Americans Will Develop Skin Cancer By Age 70?

Click here to answer this week's poll.

What’s Trending in Skin Care: November 2022

Each month, Dermatology Times® features a roundup of products trending in skin care. Find out what products are trending for the month of November.

New Tech for Skin

There are many innovative and exciting developments coming to the dermatology space, both energy-based devices and injectables.

An Overview of Harlequin Ichthyosis

Harlequin ichthyosis is a rare skin disorder with thick, large, plate-like scales over the entire body that later develop into erythroderma.

Analytics Can Play a Role for Dermatologists Working With Community Wound Care Centers

The Net Health Tissue Analytics platform helps engage patients, collect information via digital imaging that can be transmitted via an app, and provide real-time access to the progress of a study.

Research Examines Link Between Vitiligo and Systemic Sclerosis

Israeli researchers find more than five fold risk of developing systemic sclerosis among people with vitiligo.

Erythrodermic Psoriasis: A Rare Disease

Erythrodermic psoriasis, affecting about 1-2% of psoriatic patients, is a rare, potentially life-threatening variant of psoriasis.

Significant Improvements in Itch and Itch-Related Sleep Loss with Roflumilast Cream

Arcutis Biotherapeutics announced new positive data involving itch and itch-related sleep loss in adults with plaque psoriasis.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.